Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

Por: Briones, J, Novelli, S, Garcia-Marco, JA, Tomas, JF, Bernal, T, Grande, C, Canales, MA, Torres, A, Moraleda, JM, Panizo, C, Jarque, I, Palmero, F, Hernandez, M, Gonzalez-Barca, E, Lopez, D, Caballero, D

---

Publicada: 1 jul 2014

---

---

Filiaciones:
Briones, J:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Novelli, S:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Garcia-Marco, JA:
 Hosp Univ Puerta de Hierro, Madrid, Spain

Tomas, JF:
 MD Anderson Int, Madrid, Spain

Bernal, T:
 Hosp Univ Cent Asturias, Oviedo, Spain

Grande, C:
 Hosp 12 Octubre, E-28041 Madrid, Spain

Canales, MA:
 Hosp La Paz, Madrid, Spain

Torres, A:
 Hosp Reina Sofia, Cordoba, Spain

Moraleda, JM:
 Hosp Virgen Arrixaca, Murcia, Spain

Panizo, C:
 Univ Navarra Clin, Pamplona, Spain

Jarque, I:
 Hosp Univ La Fe, Valencia, Spain

Palmero, F:
 Hosp Univ Alicante, Alicante, Spain

Hernandez, M:
 Hosp Univ Canarias, Tenerife, Spain

Gonzalez-Barca, E:
 ICO Duran & Reynals, Barcelona, Spain

Lopez, D:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Caballero, D:
 Hosp Univ Salamanca, Salamanca, Spain